Hansoh Pharmaceutical Group CoHNSPF 90 Dividend Yield % is 1.23% as of Jul. 03, 2026, which is 37% above its 10-year median of 0.90. GuruFocus rates HNSPF with a GF Score™ of 90/100 and a GF Value™ of $3.00 (Modestly Overvalued). Among 518 Drug Manufacturers companies, Hansoh Pharmaceutical Group Co ranks worse than 68.15% on this metric.
During the past 12 months, Hansoh Pharmaceutical Group Co's average Dividends Per Share Growth Rate was 10.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 39.40% per year.
During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Hansoh Pharmaceutical Group Co was 63.20% per year. The lowest was 39.40% per year. And the median was 51.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Hansoh Pharmaceutical Group Co (OTCPK:HNSPF) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co Dividend Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hansoh Pharmaceutical Group Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Hansoh Pharmaceutical Group Co's Dividend Yield % falls into.
Hansoh Pharmaceutical Group Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Hansoh Pharmaceutical Group Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.231600
2025-09-22
2025-09-26
2025-10-30
Cash Dividend
semi-annually
HKD:USD 0.128520
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co (HNSPF) has a Dividend Yield % of 1.23% as of Jul. 03, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Hansoh Pharmaceutical Group Co and its competitors. This is 37% above median its historical median of 0.90. Over the past decade, Hansoh Pharmaceutical Group Co's Dividend Yield % has ranged from 0.41 to 2.06. According to the industry distribution chart, Hansoh Pharmaceutical Group Co ranks #353 out of 518 companies in the Drug Manufacturers industry, placing it in the top 68.1%.
Is Hansoh Pharmaceutical Group Co's Dividend Yield % too high?
Hansoh Pharmaceutical Group Co's current Dividend Yield % of 1.23% is 37% above median its 10-year median of 0.90. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 2.06. The Drug Manufacturers industry median Dividend Yield % is 1.95. Hansoh Pharmaceutical Group Co's value of 1.23% is 36.9% below this industry median. Based on the distribution chart, Hansoh Pharmaceutical Group Co ranks #353 out of 518 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hansoh Pharmaceutical Group Co has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hansoh Pharmaceutical Group Co's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hansoh Pharmaceutical Group Co ranks #353 out of 518 companies for Dividend Yield %. This places Hansoh Pharmaceutical Group Co in the lower half of its industry. The industry median Dividend Yield % is 1.95. Hansoh Pharmaceutical Group Co's value of 1.23% is 36.9% below this benchmark. Historically, Hansoh Pharmaceutical Group Co's own Dividend Yield % has ranged from 0.41 to 2.06 over the past decade. While the company's 10-year median is 0.90 vs. the industry median of 1.95, Hansoh Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.95, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hansoh Pharmaceutical Group Co's current Dividend Yield % of 1.23% is 36.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Hansoh Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hansoh Pharmaceutical Group Co's current Dividend Yield % is 1.23%, which is 37% above median its own 10-year median of 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hansoh Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co (HNSPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.00, compared to a current price of $3.83 — trading 27.5% above its estimated fair value. The current Dividend Yield % is 1.23%, which is 37% above median its 10-year median of 0.90 and 36.9% below the Drug Manufacturers industry median of 1.95. Hansoh Pharmaceutical Group Co's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Hansoh Pharmaceutical Group Co (HNSPF), the current Dividend Yield % is 1.23% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hansoh Pharmaceutical Group Co (HNSPF) Overvalued in 2026?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of $3.83 is trading 27.5% above its estimated GF Value™ of $3.00.
GuruFocus considers Hansoh Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for HNSPF:
Dividend Yield %: 1.23% (37% above median its 10-year median of 0.90)
GF Value™: $3.00 vs. price of $3.83 (27.5% above fair value)
Industry Position: 36.9% below the Drug Manufacturers median (#353 of 518)
No single metric tells the full story. See the HNSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hansoh Pharmaceutical Group Co Business Description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
90GF Score
Get the complete analysis for HNSPF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HNSPF has been successfully added to your 
